References
- Sohal RS. Age pigments. Elsevier/North-Holland Biomedical Press, Amsterdam 1981
- Zs.-Nagy I. Lipofuscin–1987: State of the Art (International Congress Series 782). Elsevier Science Publishers B.V., Amsterdam 1988
- Harman D. Lipofuscin and ceroid formation: The cellular recycling system. Adv Exp Med Biol 1989; 266: 3–15
- Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81–128
- Uchida K. Role of reactive aldehydes in cardiovascular diseases. Free Radic Biol Med 2000; 28: 1685–1696
- Elleder M. Chemical characterization of age pigments. Age pigments, RS Sohal. Elsevier/North-Holland Biomedical Press, Amsterdam 1981; 204–241
- Chio KS, Tappel AL. Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry 1969; 8: 2821–2826
- Chio KS, Tappel AL. Inactivation of ribonuclease and other enzymes by peroxidizing lipids and by malonaldehyde. Biochemistry 1969; 8: 2827–2832
- McGirr LG, Hadley M, Draper HH. Identification of Nα-acetyl-ε-(2-propenal)lysine as a urinary metabolite of malondialdehyde. J Biol Chem 1985; 260: 15427–15431
- Draper HH, Hadley M, Lissemore L, Laing NM, Cole PD. Identification of N-ε-(2-propenal)lysine as a major urinary metabolite of malondialdehyde. Lipids 1988; 23: 626–628
- Haberland ME, Fogelman AM, Edwards PA. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci USA 1982; 769: 1712–1716
- Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 1997; 322: 317–325
- Itakura K, Uchida K. Evidence that malondialdehyde-derived aminoenimine is not a fluorescent age pigment. Chem Res Toxicol 2001; 14: 473–475
- Kikugawa K, Machida Y, Kida M, Kurachi T. Studies on peroxidized lipids. III. Fluorescent pigments derived from the reaction of malondialdehyde and amino acids. Chem Pharm Bull 1981; 29: 3003–3011
- Kikugawa K, Ido Y. Studies on peroxidized lipids. V. Formation and characterization of 1,4-dihydropyridine-3,5-dicarbaldehydes as model of fluorescent components in lipofuscin. Lipids 1984; 19: 600–608
- Kikugawa K, Ido Y, Mikami J. Studies on peroxidized lipids. VI Fluorescent products derived from the reaction of primary amines, malondialdehyde and monofunctional aldehydes. J Am Oil Chem Soc 1984; 61: 1574–1581
- Slatter DA, Murray M, Bailey AJ. Formation of a dihydropyridinederivative as a potential cross-link derived from malondialdehyde in physiological systems. FEBS Lett 1998; 421: 180–184
- Slatter DA, Paul RG, Murray M, Bailey AJ. Reactions of lipid derived malondialdehyde with collagen. J Biol Chem 1999; 274: 19661–19669
- Ishii T, Kumazawa S, Sakurai T, Nakayama T, Uchida K. Mass spectroscopic characterization of antibody-recognized epitope: Characterization of protein modification by malondialdehyde. Chem Res Toxicol 2006; 19: 122–129
- Verbunt RJAM, Fitzmaurice MA, Kramer JR, Ratliff NB, Kittrell C, Taroni P, Cothren RM, Baraga J, Feld M. Characterization of ultraviolet laser-induced autofluorescence of ceroid deposits and other structures in atherosclerotic plaques as a potential diagnostic for lase angiosurgery. Am Heart J 1992; 123: 208–216
- Ball RY, Bindman JP, Carpenter KLH, Mitchinson MJ. Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro. Atherosclerosis 1986; 60: 173–181
- Oliver C. Lipofuscin and ceroid accumulation in experimental animals. Age pigments, RS Sohal. Elsevier/North-Holland Biomedical Press, Amsterdam 1981; 335–353
- Carpenter KLH, Ball RY, Carter NP, Woods SE, Hartley SL, Davies S, Enright JH, Mitchinson MJ. Modulation of ceroid accumulation in macrophages in vitro. Adv Exp Med Biol 1989; 266: 333–343
- Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988; 241: 215–217
- Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989; 86: 1372–1376
- Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde–lysine in serum. Arterioscler Thromb 1994; 14: 605–616
- Rosenfeld ME, Palinski S, Yla-Herttuala S, Butler S, Witztum JL. Distribution of oxidation specific lipid–protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990; 10: 336–349
- Yamada S, Kumazawa S, Ishii T, Nakayama T, Itakura K, Shibata N, Kobayashi M, Sakai K, Osawa T, Uchida K. Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine. J Lipid Res 2001; 42: 1187–1196